health benefit

Research in Review

Advance Directives, QoL-Focused Care Needed for Cancer Patients With Delirium in the ED

08/03/2017

JCP Editors

Patients with advanced cancer who visit the emergency department (ED) with delirium have increased rates of hospitalizations and ICU admissions, along with decreased survival rates, according to a recent study...

...

08/03/2017

Journal of Clinical Pathways

Research in Review

Dose Escalation of CML Treatment Improves Molecular Response Rates

08/02/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) in the chronic phase may achieve molecular response with safe and effective treatment dose escalation, according to a recent study. ----- Related Content CML Mutations...

...

08/02/2017

Journal of Clinical Pathways

Research in Review

CLL Long-Term Survival Likely to Improve With Novel Therapies

07/26/2017

JCP Editors

Novel agents are predicted to significantly improve lifetime overall survival (OS) and quality-adjusted life-years (QALYs) compared with traditional therapies for patients with chronic lymphocytic leukemia (CLL),...

Novel...

07/26/2017

Journal of Clinical Pathways

Research in Review

Model Predicts Tumor Spread in Lung Cancer

07/17/2017

JCP Editors

Genetic characteristics of lung cancer can be used to predict likelihood of metastasis, a newly developed model shows. ----- Related Content Leptomeningeal Metastases More Common in EGFR+ Lung Cancer Best...

...

07/17/2017

Journal of Clinical Pathways

Research in Review

Insulin Pump Therapy Inferior to Insulin Injections in Cost-Effectiveness

06/23/2017

JCP Editors

Continuous subcutaneous insulin infusion (CSII) is associated with increased hypoglycemia encounters and health care expenditures, according to research published in the American Journal of Managed Care (June 21,...

...

06/23/2017

Journal of Clinical Pathways

Research in Review

Blended Cognitive Behavior Therapy Decreases Fear of Cancer Recurrence

05/24/2017

JCP Editors

Survivors of cancer with fear of cancer recurrence may be effectively treated with a blended therapeutic approach involving face-to-face and online sessions, according to a study published in the Journal of Clinical...

...

05/24/2017

Journal of Clinical Pathways

Research in Review

Trastuzumab Emtansine Improves OS in Patients With HER2+ Breast Cancer

05/19/2017

JCP Editors

Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer benefit from an estimated 7 additional months of survival if treated with trastuzumab emtansine rather than the physician’s choice...

...

05/19/2017

Journal of Clinical Pathways

Research in Review

New Biomarker Helps Predict PFS in Patients With Type of NSCLC

05/05/2017

JCP Editors

Patients with ALK-rearranged non-small cell lung cancer (NSCLC) who are treated with crizotinib may experience increased progression-free survival (PFS) with a decrease in a type of circulating tumor cells, according...

...

05/05/2017

Journal of Clinical Pathways

Research in Review

MRI Results After DCIS Biopsy Unreliable, Leads to Overtreatment

05/04/2017

JCP Editors

MRI results after percutaneous biopsy for ductal carcinoma in situ (DCIS) often overestimate the extent of breast cancer, resulting in unnecessary mastectomies, according to a presentation at the American Society of...

MRI...

05/04/2017

Journal of Clinical Pathways

Research in Review

Removing Metastases Improves Survival for Patients With Kidney Cancer

04/28/2017

JCP Editors

Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...

...

04/28/2017

Journal of Clinical Pathways